Contract 80JSC023DA015
Sti Legacy, Inc. · National Aeronautics And Space Administration · July 1, 2024
Sti Legacy, Inc. was awarded a federal contract by National Aeronautics And Space Administration on July 1, 2024 for an undisclosed amount of work in research and development in biotechnology (except nanobiotechnology). It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on June 16, 2026. If all options are exercised, the contract could reach $25.00 million.
Contract details
- PIID
- 80JSC023DA015
- Award type
- Indefinite Delivery / Indefinite Quantity
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Space R&D Services; Space Flight, Research And Supporting Activities; Applied Research
- First action
- July 1, 2024
- Latest action
- June 16, 2026
Description
FOLLOWING EXECUTIVE ORDER 14398 ADDRESSING DIVERSITY, EQUITY, AND INCLUSION (DEI) DISCRIMINATION BY FEDERAL CONTRACTORS, FAR 52.222.90 ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS (APR 2026) IS AMENDED INTO BASE CONTRACT.
Modification timeline
-
June 16, 2026Mod P00006 · Other Administrative Action$0
-
March 11, 2026Mod P00005 · Novation AgreementSERVICES TO MANAGE AND PERFORM ALL WORK NECESSARY FOR THE SUCCESSFUL INTEGRATION AND ON-ORBIT OPERATIONS OF SELECTED SCIENTIFIC AND ENGINEERING WORK IN MICROGRAVITY, AS WELL AS GROUND-BASED TESTING, I…$0
-
March 11, 2026Mod P00005$0
-
August 5, 2025Mod P00004 · Other Administrative ActionSPACE TANGO SHALL PROVIDE TURNKEY SERVICES TO MANAGE AND PERFORM THE WORK.$0
-
July 1, 2024Mod P00003 · Supplemental Agreement For Work Within ScopeMANUFACTURING AND R&D PRODUCTS PROVIDED BY SPACE TANGO FOR USE ON LEO AND DEEP SPACE PLATFORMS$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Sti Legacy, Inc. | National Aeronautics And Space Administration | July 2, 2026 | $3.44M |
| Redwire Space Technologies, Inc. | National Aeronautics And Space Administration | June 24, 2026 | $0 |
| Sierra Space Corp | National Aeronautics And Space Administration | June 17, 2026 | $12.49M |
| Melanie Sauer & Associates Llc | National Aeronautics And Space Administration | March 23, 2026 | $110.0K |
| National Stem Cell Foundation Inc. | National Aeronautics And Space Administration | February 17, 2026 | $1.68M |
| Redwire Space Technologies, Inc. | National Aeronautics And Space Administration | February 13, 2026 | $415.6K |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 80JSC023DA015?
Contract 80JSC023DA015 is a federal contract awarded to Sti Legacy, Inc. by National Aeronautics And Space Administration on July 1, 2024 for an undisclosed amount of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 4 times since the base award.
Who won contract 80JSC023DA015?
Sti Legacy, Inc. won contract 80JSC023DA015 from National Aeronautics And Space Administration.
How much is contract 80JSC023DA015 worth?
Contract 80JSC023DA015 has obligated $0 to date but carries a potential ceiling of $25.00 million if fully funded and all options are exercised.